anvisa bpc 157 registro Os riscos de usar peptídeos injetáveis sem aprovação da Anvisa: 'É urgente falar disso' BPC 157 5mg $22.03 Per

AHK-Cu (Alanine-Histidine-Lysine Copper Tripeptide-3) is a copper-binding peptide, similar to the well-known GHK-Cu (Copper Tripeptide-1)

It demonstrates potent anti-glioblastoma activity by: (1) blocking tumor invasion and cytokinesis (inducing polyploidy), (2) disrupting mitochondrial dynamics to elevate ROS and trigger ferroptosis, and (3) sensitizing tumors to radiotherapy/kinase inhibitors via ROS-driven PDGFR/mTOR pathway activation

In its May 2026 evaluation, the FDA identified one small meeting abstract describing a short randomized study in people with ulcerative colitis

Its side effect profile is essentially invisible